Release date: 2017-10-10
Yan Ming, CEO of Pocket Sugar Medical, said that in the beginning of 2016, he obtained B1 round financing from Cornerstone Capital, IDG, Jingwei Venture Capital and Ping An Venture Capital, with a total investment of more than 100 million yuan. At that time, the financing was mainly used for team building, hospital-side business expansion and product development.
Xu Chuansheng, the founding managing partner of Jingwei Ventures, said that the investment in the handheld sugar medicine was because “the handheld sugar medicine has the industry-leading technical advantages and clear strategic development ideas. After the rapid accumulation of a large number of basic users on the C-end, it can be extended in time. To the higher medical scene of the barrier."
According to previous reports, Palm Sugar Medical announced in October 2015 that it has received a $15 million Series A financing from IDG, Jingwei Ventures, Ping An Ventures and a venture capital institution, from October 2015 to October 2017. Yan Ming disclosed that Pocket Sugar Medical has “5 times user growth, 10 times revenue growth and nearly 200 million yuan in revenueâ€.
According to Yan Ming, the revenue of the handheld sugar medicine in 2016 was about 50 million yuan. As of October 2017, in some high-permeability areas, the company's overall business has achieved positive cash flow, which has been completed. The goal of revenue balance.
At the same time, with the release of financing news, Yan Ming disclosed a brand new product to the outside world for the first time - the medical platform SaaS open platform.
New products coming out of practice
There are four types of users of Pocket Sugar Medical: insurance companies, hospitals, online and offline cooperative pharmacies, and natural users of departmental Internet channels. In the process of contact with the hospital, they found that the hospital has a huge pain point for the diagnosis and management of diabetic patients.
The hospital has the need for chronic disease management but does not have the conditions to achieve this. “First of all, in traditional hospitals, the communication between doctors, nurses and patients is very primitive. Many of them are paper, the efficiency is very low, and the data is not recorded; let alone the data synchronization of seriously ill patients after going home. And tracking." Yan Ming said.
Need to reverse the product, Yu Ming is determined to overcome the "hard bones" of the "hospital" - the tool of the attack is the current open platform of the medical SaaS.
This platform is not a pure software platform. It is consistent with the design idea of ​​the intelligent mutual guidance module “Sugar+â€. The intelligent medical hardware module (below) intelligently upgrades the traditional medical blood glucose meter into “Touch Intelligent Blood Glucose Monitoring Deviceâ€. "Implement information data acquisition and system docking.
Pocket sugar medical doctor
"Augmented version of Sugar+?"
"not completely."
According to Yan Ming, the first problem to be solved in the hospital-side products is identification, followed by data docking and synchronization, and the realization of standardized processes, which are also the three main functions of the medical exchange system.
In terms of software, Yan Ming said that the system can customize the permission module according to each hospital workflow, install customized functions, and complete the adaptation with different brands of blood glucose meter equipment, from single department to whole hospital, from single hospital to graded diagnosis and treatment. The medical association, multi-mode data interconnection management and sharing definitions from independent systems to access hospital HIS, systematically improve the overall diagnosis and management efficiency.
Building a closed loop of business with the hospital as the core
According to previous analysis, in the second half of 2016, the market competition in the field of diabetes management entered a new stage. If the "Hundred Sugar Battle" in 2015 is the Spring and Autumn Period, and in 2016, it will enter the relatively stable Warring States stage. Each of them will want to build up in the future market competition and others can't easily break it. barrier. "Closed loop! Closed loop! Closed loop!" has become the primary issue of consideration.
Different from the micro-sugar, sugar doctors and other enterprises from the offline entity to make a closed loop, the closed-loop construction of the handheld sugar doctor is carried out around the hospital.
In the upstream, Palm Sugar and the medical device company collaborate to collect and output data.
In the middle reaches, the handheld sugar medicine cooperated with the hospital departments, from the earliest customer access, to the hospital to provide software and hardware systems for slow disease management; at the same time, the "AI auxiliary diagnosis system" based on data development by the handheld sugar medical doctor has also Start trial in the hospital.
Through the hospital-side scenario, combined with the experience of the first c-end user, the collection of health data naturally extends to the family. "The ideal state is that when the patient is discharged from the hospital, only need to upload new monitoring data in the home in real time, the doctor can remotely monitor. In the event of a critical situation, the critically ill patient can be promptly reminded to take necessary measures or return to the hospital." Yan Ming revealed that the current handheld sugar medicine is actively promoting the extension of this part of the service from hospital to home.
The industry chain continues to expand in the payment and follow-up services. The handheld sugar medicine has always had good interaction with insurance. In 2016, the insurance income accounted for about one-third of the total income of the handheld sugar medicine. In terms of medicine, the handheld sugar medicine also cooperated with the medical e-commerce, and has its own mall service. .
It is understood that nearly 500 hospitals have access to the medical payment system, and the monthly processing data has reached tens of millions.
Yan Ming told Yiou that there is only one standard for choosing a cooperative medicine hospital: the hospital is a “flow center†hospital with high blood sugar. In 2018, the handheld sugar medicine hopes to expand the number of cooperative hospitals to 1,500, and it is driven by its own strength. Different cooperation, the handheld sugar medicine will rely on the strength of the association and large pharmaceutical companies to accelerate the staking and build their own B-end moat.
Xu Chuansheng said that the handheld sugar medicine solves the efficiency pain point inside the hospital through the SaaS system, provides the efficiency of the diagnosis and treatment system, and realizes the scale expansion of the cooperative hospital within one year, and completes the construction of the B-end moat. This business extension further opens the company's business. The upper limit of space.
From health management platform to chronic disease data platform
At the beginning of its establishment in 2014, the positioning of the handheld sugar doctor was the management of blood sugar health; now, Yu Ming describes the palm sugar medicine as the “chronic data platformâ€.
After the artificial intelligence fired in 2017, its application in the medical field has received extensive attention. According to the "2017 Artificial Intelligence-enabled Medical Industry Research Report" released by Yiou Think Tank, there are currently 8 application scenarios for the application of artificial intelligence in the medical field, and the auxiliary diagnosis is not only a big scene, but also the current artificial intelligence in the industry. A judgement of the status of the medical field.
Yan Ming admits that artificial intelligence is the most popular in the medical field is image recognition. The "AI-assisted diagnosis system" of the handheld medicine doctor is more of natural semantic recognition. In the process of implementation, unlike the relative independence of the imaging department, the cardiologists and internal medicines of the handheld sugar medicines have certain standardizations themselves. After the data is obtained by the handheld sugar doctors, they will be standardized twice and further explored.
"The big logic of artificial intelligence in medical applications is basically the same, and the hard point is in the algorithm itself and the source of big data."
It is understood that in order to support the rapid development of the business, the scale of the handheld sugar medical team has expanded from more than 80 to nearly 200 in one year, including about 60 technicians - about twice the number of technicians a year ago.
In terms of data sources, Yan Ming revealed that there are tens of millions of new data added every month to the handheld sugar medicine. "I can continue to train, and our data has the most latitude, the greatest medical value and the largest amount."
When talking about the next development plan, Yan Ming said that it will continue to optimize the software and hardware of the medical payment system; accelerate the layout of the hospital-side business, extending from the East China region to Central China, North China, Northeast China and other regions as soon as possible; relying on stable mass Data source, continue to train and optimize the "AI Auxiliary Diagnostic System".
Source: billion euro network
Electric Eyebrow Remover,Electric Eyebrow Trimmer,Automatic Eyebrow Trimmer,Best Electric Eyebrow Trimmer
Shenzhen Jie Zhong Lian Investment Co., Ltd. , https://www.szmeizon.com